Evidence map›Paper›PMID 40901317›Full record

ArticleWorld journal of clinical oncology2025

Prognostic role of Ki-67 in colorectal carcinoma: Development and evaluation of machine learning prediction models.

Da-Tong Zeng, Ming-Jie Li, Rui Lin, Wei-Jian Huang, Shi-De Li, Wan-Ying Huang, Bin Li, Qi Li, Gang Chen, Jia-Shu Jiang

Abstract read
In one paragraph

Article in World journal of clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. First-line treatment efficacy and prognostic model in RAS-mutant metastatic colorectal cancer: a real-world study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Da-Tong ZengDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Ming-Jie LiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Rui LinDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Wei-Jian HuangDepartment of Pathology, Red Cross Hospital of Yulin, Yulin 537000, Guangxi Zhuang Autonomous Region, China.
Shi-De LiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Wan-Ying HuangDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Bin LiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Qi LiDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Gang ChenDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Jia-Shu JiangDepartment of International Cooperation and External Exchange, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China. jiangjiashu115@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKi-67 is a routine test item in clinical pathology departments. However, its prognostic value requires further investigation, especially in the context of research using machine learning (ML), which remains relatively underdeveloped.

aimTo investigate the prognostic value of Ki-67 in cases of colorectal carcinoma (CRC) and explore the potential application of ML algorithms to predict the Ki-67 index.

methodsCase data and pathological sections from two centers were systematically collected. To analyze the prognostic value of the Ki-67 index in CRC, multiple cutoff values were established. Meanwhile, by virtue of the histological features presented in the hematoxylin and eosin-stained CRC images, three mainstream ML algorithms, support vector machine (SVM), random forest (RF), and eXtreme gradient boosting (XGBoost) were employed to construct prediction models. Subsequently, the potential of these algorithms to classify and predict the Ki-67 index was explored.

resultsNon-parametric tests revealed that Ki-67 ≥ 40% correlated with a high histological grade (

conclusionIn algorithmic model predictions, the SVM, RF, and XGBoost models achieved training AUC values of 0.851, 0.948, and 0.872, respectively, with corresponding test set AUC values of 0.795, 0.755, and 0.750, respectively. During external validation, their AUC values for predicting Ki-67 status reached 0.757, 0.749, and 0.783, respectively.

Indexed as

Colorectal carcinomaKi-67Machine learningPredictionPrognosis

Identifiers

PMID40901317
PMCPMC12400219

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.